NEW YORK—Retina-AI has developed and released the first Artificial Intelligence mobile app for eyecare providers. The app—Fluid Intelligence by Retina-AI—detects macula edema and sub-retinal fluid on O.C.T retinal scans with greater than 90 percent accuracy, according to its developers.

Both macula edema and sub-retinal fluid are key disease markers that may indicate the presence of any number of retinal diseases including: diabetic macula edema, exudative macular degeneration, cystoid macula edema after cataract surgery, retinal vein occlusion macula edema, central serous chorioretinopathy, uveitic macula edema, and macula-off retinal detachments. Fluid Intelligence by Retina-AI is can be used as a screening tool for any one of these diseases.

Fluid Intelligence by Retina-AI will help eyecare professionals by guiding specialized retina care at the click of a button. For instance, if an optometrist has a patient in clinic who has macula degeneration, and is unsure if it is actively-wet or not, the optometrist can take a picture of the O.C.T. retinal scan and receive an assessment as to whether that patient urgently needs an eye injection. To provide this clinical assessment, Fluid Intelligence by Retina-AI uses expertly-designed machine learning AI algorithms running in the cloud.

"We are proud to be the very first in eyecare in the world to bring the power of AI to mobile devices in the clinic,” said Retina-AI's founder, CEO and chief software architect, Stephen G. Odaibo, MD, who is a retina specialist and board-certified ophthalmologist. “Our overall goal is to increase access to high quality specialized retina care around the world."

See the video about Retina-AI below.

Fluid Intelligence by Retina-AI is available for download on the App Store here. The Android version is coming soon.